Tuberc Respir Dis TRD Tuberculosis and Respiratory Diseases 1738-3536 2005-6184 The Korean Academy of Tuberculosis and Respiratory Diseases 10.4046/trd.2010.68.6.319 Review Respiratory Review of 2010: Pneumonia Kim Yun Seong M.D. Department of Internal Medicine, Pusan National University School of Medicine, Yangsan, Korea. Address for correspondence: Yun Seong Kim, M.D. Department of Internal Medicine, Pusan National University School of Medicine, Beomeo-ri, Mulgeum-eup, Yangsan 626-870, Korea. Phone: 82-55-360-1414, Fax: 82-55-360-1757, yskimdr@yahoo.co.kr 06 2010 30 06 2010 68 6 319 327 26 05 2010 26 05 2010 Copyright © 2010. The Korean Academy of Tuberculosis and Respiratory Diseases. All rights reserved. 2010

Pneumonia represents a spectrum of diseases that range from community-acquired to health care-associated pneumonia. Despite advances in diagnosis, antimicrobial therapy, and supportive care, pneumonia remains an important cause of morbidity and mortality, particularly in elderly patients and in those with significant comorbidities. Community-acquired pneumonia (CAP) is the leading cause of death from infectious disease in Korea. This article provides a synopsis of recent studies regarding various types of pneumonia, with a focus on CAP.

 Pneumonia Community-Acquired Infections Song JH Jung KS Kang MW Kim DJ Pai H Suh GY Treatment guidelines for community-acquired pneumonia in Korea: an evidence-based approach to appropriate antimicrobial therapy Tuberc Respir Dis 2009 67 281 302 Korea National Statistical Office Annual report on the cause of death statistics 2007: nationwide 2007 Daejeon Korea National Statistical Office Schuetz P Christ-Crain M Thomann R Falconnier C Wolbers M Widmer I Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial JAMA 2009 302 1059 1066 Whitney CG Farley MM Hadler J Harrison LH Lexau C Reingold A Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United-States N Engl J Med 2000 343 1917 1924 Shehab N Patel PR Srinivasan A Budnitz DS Emergency department visits for antibiotic-associated adverse events Clin Infect Dis 2008 47 735 743 Christ-Crain M Jaccard-Stolz D Bingisser R Gencay MM Huber PR Tamm M Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial Lancet 2004 363 600 607 Menendez R Torres A Zalacain R Aspa J Martin-Villasclaras JJ Borderias L Guidelines for the treatment of community-acquired pneumonia: predictors of adherence and outcome Am J Respir Crit Care Med 2005 172 757 762 Menendez R Martinez R Reyes S Mensa J Filella X Marcos MA Biomarkers improve mortality prediction by prognostic scales in community-acquired pneumonia Thorax 2009 64 587 591 Fine MJ Auble TE Yealy DM Hanusa BH Weissfeld LA Singer DE A prediction rule to identify low-risk patients with community-acquired pneumonia N Engl J Med 1997 336 243 250 Lim WS van der Eerden MM Laing R Boersma WG Karalus N Town GI Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study Thorax 2003 58 377 382 Capelastegui A Espana PP Quintana JM Areitio I Gorordo I Egurrola M Validation of a predictive rule for the management of community-acquired pneumonia Eur Respir J 2006 27 151 157 Ewig S Kleinfeld T Bauer T Seifert K Schafer H Goke N Comparative validation of prognostic rules for community-acquired pneumonia in an elderly population Eur Respir J 1999 14 370 375 Deng JC Standiford TJ The systemic response to lung infection Clin Chest Med 2005 26 1 9 Christ-Crain M Morgenthaler NG Stolz D Muller C Bingisser R Harbarth S Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia [ISRCTN04176397] Crit Care 2006 10 R96 Niederman MS Recent advances in community-acquired pneumonia: inpatient and outpatient Chest 2007 131 1205 1215 Lin MC Chen YC Wu JT Ko YC Wang CC Diagnostic and prognostic values of pleural fluid procalcitonin in parapneumonic pleural effusions Chest 2009 136 205 211 Calverley PM Anderson JA Celli B Ferguson GT Jenkins C Jones PW Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease N Engl J Med 2007 356 775 789 Ernst P Gonzalez AV Brassard P Suissa S Inhaled corticosteroid use in chronic obstructive pulmonary disease and the risk of hospitalization for pneumonia Am J Respir Crit Care Med 2007 176 162 166 Drummond MB Dasenbrook EC Pitz MW Murphy DJ Fan E Inhaled corticosteroids in patients with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis JAMA 2008 300 2407 2416 Burge PS Calverley PM Jones PW Spencer S Anderson JA Maslen TK Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial BMJ 2000 320 1297 1303 Vestbo J Sorensen T Lange P Brix A Torre P Viskum K Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial Lancet 1999 353 1819 1823 Sin DD Tashkin D Zhang X Radner F Sjobring U Thoren A Budesonide and the risk of pneumonia: a meta-analysis of individual patient data Lancet 2009 374 712 719 Singh S Amin AV Loke YK Long-term use of inhaled corticosteroids and the risk of pneumonia in chronic obstructive pulmonary disease: a meta-analysis Arch Intern Med 2009 169 219 229 Ek A Larsson K Siljerud S Palmberg L Fluticasone and budesonide inhibit cytokine release in human lung epithelial cells and alveolar macrophages Allergy 1999 54 691 699 Crim C Calverley PM Anderson JA Celli B Ferguson GT Jenkins C Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results Eur Respir J 2009 34 641 647 Fine MJ Smith MA Carson CA Mutha SS Sankey SS Weissfeld LA Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis JAMA 1996 275 134 141 Lisboa T Blot S Waterer GW Canalis E de Mendoza D Rodriguez A Radiologic progression of pulmonary infiltrates predicts a worse prognosis in severe community-acquired pneumonia than bacteremia Chest 2009 135 165 172 Venditti M Falcone M Corrao S Licata G Serra P Outcomes of patients hospitalized with community-acquired, health care-associated, and hospital-acquired pneumonia Ann Intern Med 2009 150 19 26 Obaro SK Monteil MA Henderson DC The pneumococcal problem BMJ 1996 312 1521 1525 Huss A Scott P Stuck AE Trotter C Egger M Efficacy of pneumococcal vaccination in adults: a meta-analysis CMAJ 2009 180 48 58 Fine MJ Smith MA Carson CA Meffe F Sankey SS Weissfeld LA Efficacy of pneumococcal vaccination in adults. A meta-analysis of randomized controlled trials Arch Intern Med 1994 154 2666 2677 Moberley S Holden J Tatham DP Andrews RM Vaccines for preventing pneumococcal infection in adults Cochrane Database Syst Rev 2008 1 CD000422 Jefferson T Rivetti D Rivetti A Rudin M Di Pietrantonj C Demicheli V Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review Lancet 2005 366 1165 1174 Fagon JY Chastre J Domart Y Trouillet JL Pierre J Darne C Nosocomial pneumonia in patients receiving continuous mechanical ventilation. Prospective analysis of 52 episodes with use of a protected specimen brush and quantitative culture techniques Am Rev Respir Dis 1989 139 877 884 Kollef MH Ventilator-associated pneumonia. A multivariate analysis JAMA 1993 270 1965 1970 Vincent JL Nosocomial infections in adult intensivecare units Lancet 2003 361 2068 2077 Nardino RJ Vender RJ Herbert PN Overuse of acid-suppressive therapy in hospitalized patients Am J Gastroenterol 2000 95 3118 3122 Pham CQ Regal RE Bostwick TR Knauf KS Acid suppressive therapy use on an inpatient internal medicine service Ann Pharmacother 2006 40 1261 1266 Parente F Cucino C Gallus S Bargiggia S Greco S Pastore L Hospital use of acid-suppressive medications and its fall-out on prescribing in general practice: a 1-month survey Aliment Pharmacol Ther 2003 17 1503 1506 Herzig SJ Howell MD Ngo LH Marcantonio ER Acid-suppressive medication use and the risk for hospital-acquired pneumonia JAMA 2009 301 2120 2128 Qadeer MA Richter JE Brotman DJ Hospital-acquired gastrointestinal bleeding outside the critical care unit: risk factors, role of acid suppression, and endoscopy findings J Hosp Med 2006 1 13 20 Centers for Disease Control and Prevention (CDC) Swine influenza A (H1N1) infection in two children--Southern California, March-April 2009 MMWR Morb Mortal Wkly Rep 2009 58 400 402 Perez-Padilla R de la Rosa-Zamboni D Ponce de Leon S Hernandez M Quinones-Falconi F Bautista E Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico N Engl J Med 2009 361 680 689 Louie JK Acosta M Winter K Jean C Gavali S Schechter R Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California JAMA 2009 302 1896 1902